This fundamental difference means they produce different metabolic effects and weight loss outcomes, which influences how your body responds during a transition
The science: why GLP-1 medications change your gut Semaglutide is a GLP-1 receptor agonist
Avoid foods that trigger your symptoms
In healthy cardiomyocytes, fatty acids, branched-chain amino acids, and, under certain conditions, ketone bodies serve as the primary energy sources to meet increased energy demands, driving ATP production via the mitochondrial respiratory chain
The exceptions are the ones that went through the full pharmaceutical pipeline: insulin, GLP-1 drugs like semaglutide, and a handful of others
Losing muscle and fat creates the skinny-fat aesthetic due to a lack of tone and structure in the physique